If you’ve just been diagnosed with lymphoma, a clinical study might be the last thing on your mind.

But there are many reasons to consider taking part in one.

We’re running the SKYGLO clinical study to learn about the effects of an approved large B-cell lymphoma (LBCL) treatment called Pola-R-CHP when combined with an investigational drug.